Monday, July 05, 2021 5:35:58 PM
If the vaccines can't keep pace with the variants and/or just aren't as effective as hoped for and anticipated then the therapeutics are, of course, next on the agenda.
As said recently, big Pharma and Governmental agencies have painted themselves into a corner and Zyesami is and has been patiently awaiting it's turn to be lead onstage for it's introduction to the World.
As basically the only therapeutic for the most critically ill and therefore for the moderate and severely ill, also, right? this drug is mandated by "all" criteria for an EUA within the next two weeks.
Saroja, as always bringing new, good news to light shines our focus on the inhaled trial, too, with it's August 15th. primary completion date.
The heat is building for the fire to begin and then to explode in flames stimulating increasing share valuation. We are very close to beginning this race to fill the medicine chests of the World's hospitals and Governmental agencies anxious to have a therapeutic to save the most seriously ill from Covid-19.
We are poised and ready, don't shoot your load too quickly as this story is in the early stages of unfolding. The taste of victory is sweet, sweet still is the taste of victory with patience and forethought.
~ Money Making Money ~
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM